Cargando…
MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells
BACKGROUND: The effectiveness of chemotherapy for gastric cancer is largely limited by either intrinsic or acquired drug resistance. In this study, we aimed to explore the association between miR-30a dysregulation and multidrug resistance (MDR) in gastric cancer cells. MATERIAL/METHODS: We recruited...
Autores principales: | Li, Chunying, Zou, Jinhai, Zheng, Guoqi, Chu, Jiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123779/ http://dx.doi.org/10.12659/MSM.898415 |
Ejemplares similares
-
Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction
por: Bukauskas, Tomas, et al.
Publicado: (2019) -
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017) -
Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer
por: Cheng, Jieyao, et al.
Publicado: (2020) -
ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
por: Tan, Bibo, et al.
Publicado: (2018) -
Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
por: Xu, Yan, et al.
Publicado: (2013)